Upcoming events

Cardio Poll: your practice in perspective

These short questions focus on daily practice in interventional cardiology. Participate in one of our quick polls and see how your practice compares with that of the PCRonline community!

Filter By

6 results

Cardio Poll: In which proportion of primary PCI cases do you perform thrombectomy?

These short questions focus on daily practice in interventional cardiology. Participate in this poll and see how your practice compares with that of the PCRonline community!

Cardio Poll: How will the SMART DATE study results impact your clinical practice?

The recent SMART-DATE trial ultimately showed non-inferiority for MACE of 6 months vs. 12 months DAPT in ACS patients treated with current generation DES. Yet, myocardial infarction (a secondary endpoint) was increased by 1% in the short DAPT group and no difference for stent thrombosis and major bleeding was observed between the two treatment arms.

Cardio Poll: ODYSSEY OUTCOMES - will Alirocumab (a PCSK-9 inhibitor) improve cardiovascular outcomes in patients with a recent acute coronary syndrome?

The ODYSSEY OUTCOMES trial will test the hypothesis that Alirocumab (a PCSK-9 inhibitor that further reduces LDL cholesterol) improves cardiovascular outcomes in patients with a recent acute coronary syndrome (less than 1 year).

Cardio Poll: NOTION - impact of TAVR vs. SAVR at 5 years in patients with aortic stenosis (most at low surgical risk)

The NOTION trial evaluated the impact of a treatment with TAVR vs. SAVR in patients with aortic stenosis, mostly at low surgical risk. Outcomes at 5 years will be now presented.

Cardio Poll: SMART DATE - is 6 months of DAPT as effective as 12 months in patients with ACS treated with PCI and current drug-eluting stents?

The SMART DATE trial will test the hypothesis that 6 months of DAPT are as effective as 12 months in patients with an acute coronary syndrome treated with PCI and current drug-eluting stent implantation (everolimus-eluting stents, zotarolimus-eluting stents, or biolimus A9-eluting stents)

Cardio Poll: When do most of my STEMI patients undergoing primary PCI receive the loading dose of ticagrelor, prasugrel or clopidogrel?

These short questions focus on daily practice in interventional cardiology. Participate in this poll and see how your practice compares with that of the PCRonline community!